News About: R&D
11,800 million won of government subsidy on drug R&D.
The MOHW reported "2000 health, medical technology research and development implementation project" on March 10, which included 1) 11,790 million won for the drug R&D, 2) 3,670 million won for the medical science 3) 3...
Functional cosmetics allowed to label its efficacy and indications.
To prepare the implementation of the cosmetic law taking effect from the upcoming July 1, the MOHW drafted the working rules and enforcement decree of the cosmetic law, allowing active ingredients, efficacies, indicat...
Domestic companies to rush in bioengineering industry.
Having assessed the bio-engineering industry as a super high technological and value added areas, many domestic enterprises including pharmaceutical manufacturers tried to make an investment rush.
Korea Industrial Re...
Domestic drug companies rush in Cisapride development.
Local drug companies rushed in a market search of Cisapride (Brand name: Prepulcid), a gastric motility enhancer, originally developed by Janssen, who has enjoyed the market with this product since long time but now e...
Stock prices of pharmaceutical industry sensitively moved by new drug development.
Overall stock prices of pharmaceutical industries last year showed an ultimate bipolar phenomenon in the bourse with a great wave of fluctuation, manifesting comparatively higher figures with the R&D oriented pharmace...
Law pertaining to new drug R&D promotion from natural resources.
The National Assembly enacted the law pertaining to new drug R&D promotion from natural resources to make a bridgehead for advancing the domestic drug industry in the 21st century.
The law jointly raised by 13 ruling...
Revised criteria on drug revaluation announced to be legislated
The KFDA announced to legislate "Revised bill for drug revaluation standard" on Nov. 12 for the purpose of supplementing problems and shortcomings as resulted from revaluation and examination of the product on subject...
Uniformity in number of patients for clinical test to be modified.
The new drug re-evaluation system implemented from 1995 has to be reasonably readjusted in its provisional requirement of tested patient numbers that should be varied by different preparations in consideration with ea...
Development of intermediary compounds for 4th generation antibiotics in progress.
Daewoong Chemical (President: Mr. Moon Soon-ku) has succeeded in developing the key intermediary compounds (DW-1150) for the new 4th generation of Phenem and Carbaphenem antibiotics,
The core technology of the i...
1,500 billion won subsidy for new drug R&D by 2010.
The MOHW announced in the meeting of the parliamentary inspection of the government administration that 1,500 billion won of financial subsidy would be provided for the R&D of new drug discovery by year 2010 especial...
